Auction for 2023/2024 Delivery Year Attracts a Diverse and Reliable Resource Mix at Lower Cost for Consumers VALLEY FORGE, Pa., June 21, 2022 /PRNewswire/ — PJM Interconnection announced today the successful procurement of resources in its annual capacity auction to meet electricity…
Related Posts
Transform Materials Appoints Rachelle Goebel as Chief Executive Officer
Ms. Goebel brings more than 25 years of experience in the industrial gas and gas-processing industries RIVIERA BEACH, Fla. ,…
GameChange Solar oznamuje plánované otevření nové linky na výrobu solárních trackerů o výkonu 6 GW na Středozápadě a zvýšila kapacitu v USA na 14 GW
NORWALK, Connecticut, 5. srpna 2022 /PRNewswire/ — Společnost GameChange Solar dnes oznámila, že v únoru 2023 zahájí na americkém Středozápadě…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.